速递|超8亿美元交易达成!诺和诺德布局非GLP-1减重药物

GLP1减重宝典
Jun 13

整理 | GLP1减重宝典内容团队诺和诺德正进一步巩固其在快速增长的肥胖治疗市场中的领先地位,近日宣布与Deep Apple Therapeutics达成一项最高价值达8.12亿美元的合作协议,获取针对非促胰素类GPCR靶点的小分子药物。这一战略合作是该公司一系列研发投资中的最新动作,旨在锁定下一代代谢疾病疗法。Deep Apple Therapeutics由投资机构Apple Tree ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10